Arcus Biosciences’ Quemliclustat Receives Orphan Drug Designation for Pancreatic Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. ULS
8. AWK
9. DRI
10. USO

Go back to Arcus Biosciences’ Quemliclustat Receives Orphan Drug Designation for Pancreatic Cancer
(NYSE: RCUS) Delayed: 24.97 -0.09 (0.36%)
Previous Close $25.06    52 Week High $ 
Open $25.16    52 Week Low $ 
Day High $25.29    P/E N/A 
Day Low $24.34    EPS $ 
Volume 1,717,233